Access

A journalistic investigation into access to medicines around the world

Prices

14 medicines, 61 countries. Compare and analyse the differences between them

Counterfeits

The high prices of medicines, especially on developing countries, open the door to an illegal market of dangerous counterfeits

Compulsory license

Eight years after overthrowing an antiretroviral patent, new doubts arise about the sustainability of the Brazilian government’s AIDS programme

Patents

Although there are alternative models, the use of intellectual property rights, as applied to medicine, remains mandatory for the industry

Methodology

Key Findings

Medicamentalia is a project by

Funded by

Has media partners such as

Awards

Finalist in

If you want more information, colaborate with us or republish some of our stories contact us at [email protected]